EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹4.17 Cr | ₹-5.38 Cr | ₹16 Cr | ₹18 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹4.17 Cr |
| Mar2025 | ₹-5.38 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹14 Cr |
How is Cash Flow from Operating Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.17 Cr | Positive | |
| Mar2025 | ₹-5.38 Cr | Negative | |
| Mar2024 | ₹16 Cr | -12.61 | |
| Mar2023 | ₹18 Cr | 34.06 | |
| Mar2022 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹252.0 Cr | 0.9% | 7.2% | -39.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 0.9% |
7.2% |
-39.2% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses